Thomson Reuters Corporation (TRI) is a Canadian-headquartered information services company serving legal, tax, accounting, and news professionals. It is a stock, not an ETF. The central $120 target is an average, not a guarantee, and the consensus sits at a "Moderate Buy" or "Buy" rating.
Eighteen analyst targets tracked by S&P Global produce a mean near $121.79, which rounds to the $120 figure used here. The range is notably wide—roughly $100 to $146—because analysts disagree sharply on how quickly AI products such as CoCounsel and Westlaw Precision will translate into revenue. Recent individual actions underscore the caution: Barclays lowered its target from $140 to $130 while keeping an Overweight rating, and Scotiabank trimmed its target to $135 while maintaining a Sector Outperform view. Those figures sit near the middle of the range, while the most cautious firms cluster near $100.
Notably, targets have been drifting lower through 2026, reflecting both a pullback in the share price and softer near-term growth assumptions. This matters because the average is pulled down by the cautious end of the range; investors should not treat the mean as a firm forecast.
The stock recently traded around $108, near the lower end of its 52-week range of roughly $76 to $164. Reaching $120 would require an advance of about 11%—a modest move by equity-market standards. Importantly, the stock was trading above $120 as recently as the past year, so the target is not an aggressive stretch; it is closer to a partial retracement of a sharp 2026 decline.
The path is complicated by valuation. Thomson Reuters trades at a P/E (price-to-earnings) ratio near 29 to 30 times trailing earnings, which is elevated for a mature information-services business. For the stock to reach $120, investors would likely need either multiple expansion on renewed AI optimism or earnings growth sufficient to support the current multiple, plus sustained execution in the company's core legal and tax franchises.
Several verified factors could support a recovery. The company reported strong third-quarter results in late 2025, with earnings and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) ahead of expectations, and announced a $1 billion share buyback. It has also invested aggressively in AI, including a multi-year Frontier AI research collaboration with Imperial College London and new legal technology tools aimed at in-house counsel.
The core business remains resilient, with recurring subscription revenue, a low beta near 0.20 indicating defensive characteristics, and a dividend yield around 2.4%. If AI adoption accelerates and analyst revisions turn higher again, the path toward $120 becomes more direct.
The principal obstacle is competition. A wave of lower-cost, AI-native legal and research tools has raised questions about whether Thomson Reuters can defend its pricing power and margins. Slower-than-expected client adoption of AI products would pressure growth assumptions that underpin today's valuation.
Valuation compression is a related risk: if investors conclude the premium P/E multiple is no longer justified, the stock could remain below $120 even if fundamentals hold up. Currency exposure adds another variable, since the company reports in U.S. dollars but operates substantially in Canadian dollars and other currencies. Finally, the persistent downward drift in analyst targets through 2026 signals that the sell-side itself remains uncertain about the growth outlook.
From a technical perspective, the stock is trading well below its prior 52-week high near $164, meaning the longer-term trend has been under pressure. The $100 level represents a meaningful psychological and technical floor, closely matching the low end of the analyst target range and a level where buyers have previously stepped in. On the upside, the $130 to $135 zone—where recent Barclays and Scotiabank targets sit—forms a natural resistance area that the stock would need to clear on the way toward any higher objective. The $120 target itself sits in a zone between these support and resistance bands.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ, and no specific horizon is guaranteed. Investors should watch the next earnings report, scheduled for early November 2026, along with management's full-year guidance and any commentary on AI adoption and pricing. Additional items to monitor include analyst revisions (which have been trending lower), the pace of the buyback, foreign-exchange moves, and any news on AI product rollouts or competitive responses. For a stock like this, the single most important catalyst is evidence that AI investments are converting into sustained revenue growth.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening. For a name like Thomson Reuters, where the technical picture and analyst sentiment are both evolving, an automated signal can offer a useful, data-driven complement to fundamental research. Traders seeking an edge can explore the platform to see how the signals apply to their watchlists.
Can Thomson Reuters (TRI) reach $120? The question is answerable only in probabilities, not certainties. The $120 target—the rounded average of roughly 18 analyst price targets—requires a modest advance of about 11% from current levels and would merely restore the stock to a level it held within the past year. Support comes from resilient recurring revenue, AI product investment, and a $1 billion buyback. Obstacles include elevated valuation, intensifying AI competition, and a pattern of downward analyst revisions. With targets spanning roughly $100 to $146, the sell-side itself is divided. The most important factor to monitor next is whether upcoming earnings and guidance demonstrate that AI adoption is converting into tangible growth—because that, more than any single target, will determine the stock's next leg.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, TRI has been closely correlated with RELX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRI jumps, then RELX could also see price increases.
| Ticker / NAME | Correlation To TRI | 1D Price Change % | ||
|---|---|---|---|---|
| TRI | 100% | +2.16% | ||
| RELX - TRI | 68% Closely correlated | -0.66% | ||
| EXPO - TRI | 50% Loosely correlated | +0.83% | ||
| LZ - TRI | 47% Loosely correlated | +1.07% | ||
| VRSK - TRI | 47% Loosely correlated | +0.77% | ||
| CPRT - TRI | 45% Loosely correlated | -0.88% | ||
More | ||||
| Ticker / NAME | Correlation To TRI | 1D Price Change % |
|---|---|---|
| TRI | 100% | +2.16% |
| TRI (2 stocks) | 97% Closely correlated | +5.37% |
| Office Equipment/Supplies (46 stocks) | 10% Poorly correlated | +0.44% |
| Producer Manufacturing (348 stocks) | 2% Poorly correlated | -1.74% |